The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease.
Aged
Anti-Bacterial Agents
/ standards
Bronchiectasis
/ complications
Disease Progression
Female
Follow-Up Studies
Humans
Lung Diseases
/ microbiology
Male
Middle Aged
Mycobacterium avium Complex
/ isolation & purification
Mycobacterium avium-intracellulare Infection
/ diagnosis
Prevalence
Remission, Spontaneous
Republic of Korea
/ epidemiology
Retrospective Studies
Sputum
/ drug effects
Clinical course
Conversion
MAC
Treatment
Journal
Respiratory medicine
ISSN: 1532-3064
Titre abrégé: Respir Med
Pays: England
ID NLM: 8908438
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
11
08
2018
revised:
28
12
2018
accepted:
03
02
2019
entrez:
10
4
2019
pubmed:
10
4
2019
medline:
2
5
2020
Statut:
ppublish
Résumé
We aimed to investigate the natural history of non-cavitary nodular bronchiectatic (NC-NB) Mycobacterium avium complex (MAC) lung disease (LD). Among all patients diagnosed with NC-NB MAC LD between March 2000 and December 2013, 551 patients who were followed until December 2017 were enrolled at a tertiary referral center in South Korea. Patients were subdivided into progressive and stationary groups, depending on whether treatment was initiated within 3 years after diagnosis. We investigated the proportion of patients not receiving anti-MAC treatment within 3 years after the diagnosis. The rate for spontaneous sputum conversion in the untreated group was also calculated. The mean age of 551 patients was 61.1 years. During the median 5.8 years of follow-up, 323 (58.6%) patients received treatment within 3 years (progressive group), whereas the remaining 228 (41.4%) patients did not (stationary group). Multivariate analysis revealed that age ≤ 60 years, a positive sputum smear, the presence of systemic symptoms, body mass index >18.5 kg/m Among patients diagnosed with NC-NB MAC LD, approximately 40% did not receive antibiotic treatment within 3 years of diagnosis. Moreover, about 50% of untreated patients experienced spontaneous sputum conversion.
Identifiants
pubmed: 30961950
pii: S0954-6111(19)30043-5
doi: 10.1016/j.rmed.2019.02.007
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
45-50Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.